Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	256.47M +67.0%
Revenue (ttm)	122.36M +37.3%
Net Income	19.66M +17.1%
EPS	0.03 +19.6%
Shares Out	581.33M
PE Ratio	13.18
Forward PE	11.07
Dividend	0.01 (1.42%)
Ex-Dividend Date	May 28, 2026

Volume	5,544
Average Volume	188,396
Open	0.5840
Previous Close	0.6000
Day's Range	0.5840 - 0.6280
52-Week Range	0.3200 - 0.8300
Beta	0.35
RSI	45.09
Earnings Date	Sep 2, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 7,137
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2025, LON:IDHC's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP